| A50 | Congenital syphilis |
| A50.1 | Early congenital syphilis, latent |
| A50.4 | Late congenital neurosyphilis [juvenile neurosyphilis] |
| A50.40 | Late congenital neurosyphilis, unspecified |
| A50.49 | Other late congenital neurosyphilis |
| A50.6 | Late congenital syphilis, latent |
| A50.7 | Late congenital syphilis, unspecified |
| A50.9 | Congenital syphilis, unspecified |
| A51 | Early syphilis |
| A51.0 | Primary genital syphilis |
| A51.3 | Secondary syphilis of skin and mucous membranes |
| A51.32 | Syphilitic alopecia |
| A51.39 | Other secondary syphilis of skin |
| A51.4 | Other secondary syphilis |
| A51.41 | Secondary syphilitic meningitis |
| A51.42 | Secondary syphilitic female pelvic disease |
| A51.49 | Other secondary syphilitic conditions |
| A51.5 | Early syphilis, latent |
| A52 | Late syphilis |
| A52.1 | Symptomatic neurosyphilis |
| A52.10 | Symptomatic neurosyphilis, unspecified |
| A52.19 | Other symptomatic neurosyphilis |
| A52.3 | Neurosyphilis, unspecified |
| A52.7 | Other symptomatic late syphilis |
| A52.79 | Other symptomatic late syphilis |
| A52.8 | Late syphilis, latent |
| A53 | Other and unspecified syphilis |
| A53.0 | Latent syphilis, unspecified as early or late |
| A53.9 | Syphilis, unspecified |
| A54 | Gonococcal infection |
| A56 | Other sexually transmitted chlamydial diseases |
| A56.11 | Chlamydial female pelvic inflammatory disease |
| A56.8 | Sexually transmitted chlamydial infection of other sites |
| A60 | Anogenital herpesviral [herpes simplex] infections |
| A60.0 | Herpesviral infection of genitalia and urogenital tract |
| A60.00 | Herpesviral infection of urogenital system, unspecified |
| A60.01 | Herpesviral infection of penis |
| A60.02 | Herpesviral infection of other male genital organs |
| A60.03 | Herpesviral cervicitis |
| A60.04 | Herpesviral vulvovaginitis |
| A60.09 | Herpesviral infection of other urogenital tract |
| A60.1 | Herpesviral infection of perianal skin and rectum |
| A60.9 | Anogenital herpesviral infection, unspecified |
| B00 | Herpesviral [herpes simplex] infections |
| B00.0 | Eczema herpeticum |
| B00.1 | Herpesviral vesicular dermatitis |
| B00.3 | Herpesviral meningitis |
| B00.4 | Herpesviral encephalitis |
| B00.5 | Herpesviral ocular disease |
| B00.53 | Herpesviral conjunctivitis |
| B00.81 | Herpesviral hepatitis |
| B00.82 | Herpes simplex myelitis |
| B00.89 | Other herpesviral infection |
| B00.9 | Herpesviral infection, unspecified |
| B02 | Zoster [herpes zoster] |
| B02.1 | Zoster meningitis |
| B02.23 | Postherpetic polyneuropathy |
| B10.0 | Other human herpesvirus encephalitis |
| D68 | Other coagulation defects |
| D68.61 | Antiphospholipid syndrome |
| D68.62 | Lupus anticoagulant syndrome |
| E10.41 | Type 1 diabetes mellitus with diabetic mononeuropathy |
| E71.522 | Adrenomyeloneuropathy |
| F01 | Vascular dementia |
| F02 | Dementia in other diseases classified elsewhere |
| F03 | Unspecified dementia |
| F03.9 | Unspecified dementia |
| F03.90 | Unspecified dementia without behavioral disturbance |
| F03.91 | Unspecified dementia with behavioral disturbance |
| F06.0 | Psychotic disorder with hallucinations due to known physiological condition |
| F10.27 | Alcohol dependence with alcohol-induced persisting dementia |
| F18.17 | Inhalant abuse with inhalant-induced dementia |
| G31.09 | Other frontotemporal dementia |
| G31.83 | Dementia with Lewy bodies |
| G31.84 | Mild cognitive impairment, so stated |
| G58 | Other mononeuropathies |
| G58.9 | Mononeuropathy, unspecified |
| G60 | Hereditary and idiopathic neuropathy |
| G60.0 | Hereditary motor and sensory neuropathy |
| G60.3 | Idiopathic progressive neuropathy |
| G60.8 | Other hereditary and idiopathic neuropathies |
| G61 | Inflammatory polyneuropathy |
| G61.1 | Serum neuropathy |
| G62 | Other and unspecified polyneuropathies |
| G62.9 | Polyneuropathy, unspecified |
| G63 | Polyneuropathy in diseases classified elsewhere |
| G90.0 | Idiopathic peripheral autonomic neuropathy |
| G99 | Other disorders of nervous system in diseases classified elsewhere |
| G99.0 | Autonomic neuropathy in diseases classified elsewhere |
| I32 | Pericarditis in diseases classified elsewhere |
| I39 | Endocarditis and heart valve disorders in diseases classified elsewhere |
| I40 | Acute myocarditis |
| I40.0 | Infective myocarditis |
| I40.1 | Isolated myocarditis |
| I40.8 | Other acute myocarditis |
| I40.9 | Acute myocarditis, unspecified |
| I41 | Myocarditis in diseases classified elsewhere |
| I73 | Other peripheral vascular diseases |
| I73.0 | Raynaud's syndrome |
| I73.00 | Raynaud's syndrome without gangrene |
| I73.01 | Raynaud's syndrome with gangrene |
| J39 | Other diseases of upper respiratory tract |
| J99 | Respiratory disorders in diseases classified elsewhere |
| L63 | Alopecia areata |
| L63.0 | Alopecia (capitis) totalis |
| L63.1 | Alopecia universalis |
| L63.8 | Other alopecia areata |
| L63.9 | Alopecia areata, unspecified |
| L64 | Androgenic alopecia |
| L64.0 | Drug-induced androgenic alopecia |
| L64.8 | Other androgenic alopecia |
| L64.9 | Androgenic alopecia, unspecified |
| L65 | Other nonscarring hair loss |
| L65.2 | Alopecia mucinosa |
| L66 | Cicatricial alopecia [scarring hair loss] |
| L66.8 | Other cicatricial alopecia |
| L66.9 | Cicatricial alopecia, unspecified |
| L93 | Lupus erythematosus |
| L93.0 | Discoid lupus erythematosus |
| L93.1 | Subacute cutaneous lupus erythematosus |
| L93.2 | Other local lupus erythematosus |
| M05.5 | Rheumatoid polyneuropathy with rheumatoid arthritis |
| M32 | Systemic lupus erythematosus (SLE) |
| M32.0 | Drug-induced systemic lupus erythematosus |
| M32.10 | Systemic lupus erythematosus, organ or system involvement unspecified |
| M32.8 | Other forms of systemic lupus erythematosus |
| M32.9 | Systemic lupus erythematosus, unspecified |
| N08 | Glomerular disorders in diseases classified elsewhere |
| N16 | Renal tubulo-interstitial disorders in diseases classified elsewhere |
| N70 | Salpingitis and oophoritis |
| N72 | Inflammatory disease of cervix uteri |
| N73 | Other female pelvic inflammatory diseases |
| N73.0 | Acute parametritis and pelvic cellulitis |
| N73.3 | Female acute pelvic peritonitis |
| N73.9 | Female pelvic inflammatory disease, unspecified |
| N74 | Female pelvic inflammatory disorders in diseases classified elsewhere |
| N77 | Vulvovaginal ulceration and inflammation in diseases classified elsewhere |
| N88 | Other noninflammatory disorders of cervix uteri |
| N89 | Other noninflammatory disorders of vagina |
| N90 | Other noninflammatory disorders of vulva and perineum |
| N98.3 | Complications of attempted introduction of embryo in embryo transfer |
| O09 | Supervision of high risk pregnancy |
| O26 | Maternal care for other conditions predominantly related to pregnancy |
| O36.01 | Maternal care for anti-D [Rh] antibodies |
| O98 | Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium |
| O98.1 | Syphilis complicating pregnancy, childbirth and the puerperium |
| O98.51 | Other viral diseases complicating pregnancy |
| O98.52 | Other viral diseases complicating childbirth |
| O98.53 | Other viral diseases complicating the puerperium |
| O99.01 | Anemia complicating pregnancy |
| O99.280 | Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester |
| O9A.41 | Sexual abuse complicating pregnancy |
| O9A.42 | Sexual abuse complicating childbirth |
| Q84.0 | Congenital alopecia |
| R41 | Other symptoms and signs involving cognitive functions and awareness |
| R43.0 | Anosmia |
| R44.3 | Hallucinations, unspecified |
| R50 | Fever of other and unknown origin |
| R50.9 | Fever, unspecified |
| T74.2 | Sexual abuse, confirmed |
| T74.21 | Adult sexual abuse, confirmed |
| T74.21XA | Adult sexual abuse, confirmed, initial encounter |
| T74.22 | Child sexual abuse, confirmed |
| T76.2 | Sexual abuse, suspected |
| T76.21 | Adult sexual abuse, suspected |
| T76.21XA | Adult sexual abuse, suspected, initial encounter |
| T76.21XD | Adult sexual abuse, suspected, subsequent encounter |
| T76.21XS | Adult sexual abuse, suspected, sequela |
| T76.22 | Child sexual abuse, suspected |
| T76.22XA | Child sexual abuse, suspected, initial encounter |
| T76.22XD | Child sexual abuse, suspected, subsequent encounter |
| T86 | Complications of transplanted organs and tissue |
| T86.4 | Complications of liver transplant |
| T86.40 | Unspecified complication of liver transplant |
| T86.41 | Liver transplant rejection |
| T86.42 | Liver transplant failure |
| T86.43 | Liver transplant infection |
| T86.49 | Other complications of liver transplant |
| Z04.4 | Encounter for examination and observation following alleged rape |
| Z04.41 | Encounter for examination and observation following alleged adult rape |
| Z04.42 | Encounter for examination and observation following alleged child rape |
| Z11.3 | Encounter for screening for infections with a predominantly sexual mode of transmission |
| Z20 | Contact with and (suspected) exposure to communicable diseases |
| Z33 | Pregnant state |
| Z34 | Encounter for supervision of normal pregnancy |
| Z34.0 | Encounter for supervision of normal first pregnancy |
| Z34.8 | Encounter for supervision of other normal pregnancy |
| Z48.23 | Encounter for aftercare following liver transplant |
| Z72.5 | High risk sexual behavior |
| Z79 | Long term (current) drug therapy |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
| Z79.52 | Long term (current) use of systemic steroids |
| Z79.89 | Other long term (current) drug therapy |
| Z79.899 | Other long term (current) drug therapy |
| Z94.4 | Liver transplant status |